KRTL BioTech

Latest News on private equity markets

Ghosn's lawyers accuse Japan officials, Nissan executives of collusion

Lawyers for former Nissan Motor Co chairman Carlos Ghosn submitted filings to the Tokyo District Court on Thursday seeking the dismissal of all charges against him and accusing Japanese officials and executives at the automaker of collusion.



5 years ago

Ghosn's lawyers seek dismissal of charges, accuse prosecutors of misconduct

Carlos Ghosn's lawyers have asked the Tokyo District Court to dismiss all charges against the former Nissan Motor Co Ltd chairman, saying prosecutors colluded with government officials and Nissan executives to oust him from his post.



5 years ago

Asian shares edge up as earnings, geopolitics sway sentiment

Asian shares pulled ahead on Thursday as corporate earnings and a ceasefire in northern Syria helped prop up sentiment, though the backdrop of trade and brexit uncertainties was enough to prevent a decisive shift towards riskier assets.



5 years ago

There's a looming financial advisor shortage. Today's professionals can help prevent it

With about 40% of financial advisors expected to retire in the next 10 years, the industry needs to attract new talent to fill those empty seats. But there's one key challenge: Many of today's students have never heard of the profession. Here's how today's advisors can help spread the word.

5 years ago

Infosys loses $6.6 billion in market cap after whistleblower complaints

India's No.2 software services exporter, Infosys Ltd , is probing whistleblower complaints that its top two executives engaged in "unethical practices" to boost short-term revenue and profit, sending its shares down 16% on Tuesday.



5 years ago

S&P 500 rises on upbeat corporate earnings; Travelers weighs on Dow

The S&P 500 rose on Tuesday, bolstered by gains in Biogen and upbeat earnings reports that eased concerns over the fallout from the U.S.-China trade war, but the Dow Jones index was pressured by a drop in McDonald's and Travelers.



5 years ago

VW speeds up production of next generation Golf

Volkswagen will start deliveries of its new Golf hatchback in December after shaving an hour off the time needed to build its flagship model, the board member responsible for production at the VW brand said on Tuesday.



5 years ago

Cambridge: Global Regulator Survey Results – Regulation of Alternative Finance is Key to Make Sector Safe to Scale for the Masses

Crowdfund Insider | JD Alois | Oct 21,2019 The Cambridge Centre for Alternative Finance (CCAF), part of the Judge School of Business at Cambridge University, has partnered with the World Bank to publish a report on the global regulation of alternative finance and innovative Fintech firms. According to the new report, the regulation of alternative

5 years ago

Lockheed Martin profit climbs, expects lower cash flow in 2020; shares gain

Lockheed Martin Corp raised its estimate for 2019 earnings on Tuesday as quarterly profit climbed 9.2% amid improved sales of its F-35 fighter jets, sending shares higher even as it forecast a lower cash flow for next year.



5 years ago

Tips for getting your Medicare drug coverage right during open enrollment

Even if you've been happy with your coverage, be aware that insurance carriers make changes from year to year that can affect the drugs they cover and how much they'll cost you.

5 years ago

McDonald's posts rare profit miss, shares drop

McDonald's Corp missed Wall Street estimates for profit for the first time in two years on Tuesday as more investment to spruce up U.S. restaurants and speed up delivery weighed on the world's biggest fast food chain, sending its shares down 3%.



5 years ago

Boeing makes progress on 737 MAX, but FAA needs weeks to review

Boeing Co is making progress toward getting its 737 MAX aircraft in the air again but the U.S. Federal Aviation Administration (FAA) will need at least several more weeks for review, FAA Administrator Steve Dickson said on Tuesday.



5 years ago

Cramer says Biogen's Alzheimer's treatment could be 'the biggest drug ever' as shares soar 30%

Drug maker Biogen announced it is seeking regulatory approval for its Alzheimer's drug, months after it stopped testing the treatment.

5 years ago

U.S. existing home sales drop more then expected in September

U.S. home sales fell more than expected in September as the market continues to struggle with a dearth of properties for sale, especially for cheaper homes.



5 years ago

SoftBank clinches deal to take over WeWork

SoftBank Group Corp agreed to spend more than $10 billion to take over WeWork, doubling down on an ill-fated investment and paying off its co-founder Adam Neumann to relinquish control, people familiar with the matter said on Tuesday.



5 years ago